Rubenbauer; Philipp

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rubenbauer; Philipp.The latest application filed is for "orally administrable modified-release pharmaceutical dosage form".

Company Profile

12.8.13

Rubenbauer; Philipp - Bensheim DE
Rubenbauer; Philipp - Dusseldorf DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Orally Administrable Modified-release Pharmaceutical Dosage Form App 20220257547 - Stroyer; Anke ; et al.	2022-08-18
Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylb- utanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient App 20220234996 - Fey; Peter ; et al.	2022-07-28
Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone Grant 11,365,179 - Hassfeld , et al. June 21, 2	2022-06-21
Orally administrable modified-release pharmaceutical dosage form Grant 11,344,519 - Stroyer , et al. May 31, 2	2022-05-31
Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-prop- ylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient Grant 11,332,435 - Fey , et al. May 17, 2	2022-05-17
Method For Preparing 2-[(3r)-3-methylmorpholin-4-yl]-4-[1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazo- L-5-yl)-1,7-naphthyridine App 20210253573 - PLATZEK; Johannes ; et al.	2021-08-19
Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylb- utanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient App 20210179541 - FEY; Peter ; et al.	2021-06-17
Orally Administrable Modified-release Pharmaceutical Dosage Form App 20210113504 - Stroyer; Anke ; et al.	2021-04-22
Method For The Preparation Of A 2,4,5-trisubstituted 1,2,4-triazolone App 20210032212 - Hassfeld; Jorma ; et al.	2021-02-04
Orally administrable modified-release pharmaceutical dosage form Grant 10,905,667 - Stroyer , et al. February 2, 2	2021-02-02
Method For Producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- Triazole Derivatives App 20200299271 - SCHIRMER; Heiko ; et al.	2020-09-24
Orally Administrable Modified-released Pharmaceutical Dosage Form App 20200237648 - STROYER; ANKE ; et al.	2020-07-30
Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivatives Grant 10,703,742 - Schirmer , et al.	2020-07-07
Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(triflu- oromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile Grant 10,676,443 - Schirmer , et al.	2020-06-09
Orally Administrable Modified-release Pharmaceutical Dosage Form App 20200030270 - Stroyer; Anke ; et al.	2020-01-30
Synthesis of copanlisib and its dihydrochloride salt Grant 10,494,372 - Peters , et al. De	2019-12-03
Method For Producing (4s)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(triflu- Oromethyl)phenyl]-1,2,3,4-tetrah App 20190248750 - Schirmer; Heiko ; et al.	2019-08-15
Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(triflu- oromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile Grant 10,316,001 - Schirmer , et al.	2019-06-11
Method For Producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- Triazole Derivatives App 20190144431 - SCHIRMER; Heiko ; et al.	2019-05-16
Synthesis Of Copanlisib And Its Dihydrochloride Salt App 20180282337 - PETERS; Jan-Georg ; et al.	2018-10-04
Method For Producing (4s)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(triflu- Oromethyl)phenyl]-1,2,3,4-tetrahydro Pyrimidine-5-carbonitrile App 20180072685 - Schirmer; Heiko ; et al.	2018-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.